Discontinued — last reported Q4 '25
Supplemental
Receivable from maturity of available-for-sale debt securities
Analysis
StatementCash Flow Statement
SectionSupplemental
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2020
Last reportedQ4 2025Feb 25, 2026
How to read this metric
An increase suggests a larger volume of maturing investments awaiting settlement, which may temporarily impact short-term liquidity.
Detailed definition
This metric tracks the amount of cash due to the company from the maturity of debt securities classified as available-fo...
Peer comparison
Commonly found in the supplemental cash flow disclosures of companies with large treasury or investment portfolios.
Metric ID:
supplemental_receivable_from_maturity_of_available_for_s_023fb8Historical Data
11 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q4 '22 | Q3 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $70.00M | $60.00M | -$45.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | — | — | — | -14.3% | -175.0% | +100.0% | — | — | — | — |
| YoY Change | — | — | — | — | — | -175.0% | — | — | — | +100.0% | — |
Range-$45.00M – $70.00M
Avg YoY Growth-37.5%
Median YoY Growth-37.5%
Receivable from maturity of available-for-sale debt securities at Other Companies
Frequently Asked Questions
- What is United Therapeutics's receivable from maturity of available-for-sale debt securities?
- United Therapeutics (UTHR) reported receivable from maturity of available-for-sale debt securities of $0.00 in Q4 2025.
- What does receivable from maturity of available-for-sale debt securities mean?
- The amount of cash owed to the company from matured debt investments that has not yet been received.